We measured c-MET pY1003 levels by immuno-precipitation in lysates prepared from the Ln18, Ln229, U118, U138, and U87MG glioma cell lines to compare with the HGF/c-MET levels we detected using the VeraTag FFPE assay format. Here, MET is linked to central nervous system cancer.